South San Francisco, CA, United States of America

Helena Kiefel

USPTO Granted Patents = 2 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helena Kiefel: Innovator in Antibody Conjugates

Introduction

Helena Kiefel is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. With a total of 2 patents, her work focuses on innovative therapeutic solutions.

Latest Patents

Helena Kiefel's latest patents include "Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates." These patents relate to antibodies and antibody conjugates that specifically bind to receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms and homologs. The disclosures also cover pharmaceutical compositions and methods for producing and utilizing these antibodies in therapeutic and diagnostic applications.

Career Highlights

Helena Kiefel is currently associated with Sutro Biopharma, Inc., where she continues to advance her research in antibody drug conjugates. Her innovative work has the potential to impact various therapeutic areas, particularly in cancer treatment.

Collaborations

Helena collaborates with talented coworkers, including Amandeep Gakhal and Abigail Yu, who contribute to her research endeavors.

Conclusion

Helena Kiefel is a key figure in the field of antibody conjugates, with her patents paving the way for new therapeutic approaches. Her contributions to biotechnology are noteworthy and continue to influence the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…